EAM Global Investors’s Endocyte, Inc. Common Stock ECYT Stock Holding History

EAM Global Investors’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-80,647	Closed	-$1.43M	–	195
2018 Q3	$1.43M	Hold	80,647	–	–	0.58%	83
2018 Q2	$1.11M	Buy	+80,647	New	+$957K	0.54%	111

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

EAM Global Investors's ECYT Position: Q4 2018 in Review

EAM Global Investors sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 80,647 shares — an estimated $1.43M sold.

EAM Global Investors first reported a position in ECYT in Q2 2018 and held it in 2 quarters. The position peaked at $1.43M in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

EAM Global Investors reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
EAM Global Investors sold 80,647 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $1.43M.
EAM Global Investors first reported a position in Endocyte, Inc. Common Stock in Q2 2018 and held it in 2 quarters.
EAM Global Investors's Endocyte, Inc. Common Stock position peaked at $1.43M in Q3 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on EAM Global Investors's 13F filing for Q4 2018, filed 13 Feb 2019.